REVENUE - Narrative (Details) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Oct. 31, 2020	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Inventory write-down		$ 42,800,000		$ 42,800,000
Inventory reserve		30,600,000		30,581,000	$ 0
Product warranty reserve		12,300,000		12,263,000	0
Net contract assets		1,600,000		1,600,000		$ 1,100,000
Revenue		87,700,000	$ 137,423,000	267,110,000	201,922,000
Accounts receivable, allowance for doubtful accounts		800,000		800,000		$ 300,000
Product revenue
Disaggregation of Revenue [Line Items]
Revenue		84,351,000	137,423,000	261,805,000	201,922,000
Product revenue | United States Department of Defense
Disaggregation of Revenue [Line Items]
Maximum percentage limit to purchase in quarterly production	45.00%
Product revenue | Cue COVID-19 Test | United States Department of Defense
Disaggregation of Revenue [Line Items]
Agreement value	$ 480,900,000
Advance for scaling	184,600,000
Agreement value for sale of product	$ 296,300,000
Grant and other revenue
Disaggregation of Revenue [Line Items]
Revenue		3,349,000	0	5,305,000	0
Grant and other revenue | Biomedical Advanced Research And Development Authority (BARDA)
Disaggregation of Revenue [Line Items]
Revenue		$ 3,300,000	$ 0	$ 5,300,000	$ 0